caa a22 4500 605491666 CHVBK 20210128100511.0 cr unu---uuuuu 210128e20151001xx s 000 0 eng 10.1007/s10147-015-0794-7 doi (NATIONALLICENCE)springer-10.1007/s10147-015-0794-7 Characteristics of neoplastic cardiac tamponade and prognosis after pericardiocentesis: a single-center study of 113 consecutive cancer patients [Elektronische Daten] [Tsugumi Takayama, Yuji Okura, Yoshinobu Okada, Keiichi Honma, Atsushi Nashimoto, Nobuaki Sato, Akira Yokoyama, Tohru Minamino] Background: Neoplastic cardiac tamponade (NCT) is a life-threatening complication of cancer. The interval between cancer diagnosis and NCT onset and the prognosis after pericardiocentesis may differ according to cancer type. Methods and results: We performed a retrospective study of 113 patients (54% male) with NCT who underwent pericardiocentesis at Niigata Cancer Center Hospital between 1992 and 2013. Mean age at NCT was 61.2years (range 15.9-94.8years). The most common underlying cancers were lung cancer (59.2%), breast cancer (21.2%), lymphoma/leukemia (5.3%), and gastric/esophageal cancer (5.3%). The median time from cancer diagnosis to NCT onset was 9.0, 60.4, 5.6, and 8.0months for lung cancer, breast cancer, lymphoma/leukemia, and gastric/esophageal cancer, respectively. Kaplan-Meier survival estimates were worse for breast cancer patients with NCT than for matched breast cancer patients without NCT (P<0.0001). Median survival time after pericardiocentesis was 2.9, 4.2, 2.3, and 0.6months for lung cancer, breast cancer, lymphoma/leukemia, and gastric/esophageal cancer, respectively; one-year survival after pericardiocentesis was 6.0, 16.7, 33.3, and 0%, respectively. Conclusions: The interval between cancer diagnosis and NCT onset, the impact of NCT on prognosis, and the prognosis after pericardiocentesis differed according to cancer type. Healthcare practitioners caring for patients with NCT should recognize the differences between cancer types and customize their care accordingly. Japan Society of Clinical Oncology, 2015 Neoplastic cardiac tamponade nationallicence Pericardiocentesis nationallicence Prognosis nationallicence Takayama Tsugumi Department of Cardiology, Niigata Cancer Center Hospital, Chu-o-ku Kawagishicho 2-15-3, 951-8560, Niigata, Japan aut Okura Yuji Department of Cardiology, Niigata Cancer Center Hospital, Chu-o-ku Kawagishicho 2-15-3, 951-8560, Niigata, Japan aut Okada Yoshinobu Department of Internal Medicine, Kamo Hospital, Niigata, Japan aut Honma Keiichi Department of Pathology, Niigata Cancer Center Hospital, Niigata, Japan aut Nashimoto Atsushi Department of Digestive Surgery, Niigata Cancer Center Hospital, Niigata, Japan aut Sato Nobuaki Department of Breast Surgery, Niigata Cancer Center Hospital, Niigata, Japan aut Yokoyama Akira Department of Respiratory Medicine, Niigata Cancer Center Hospital, Niigata, Japan aut Minamino Tohru Department of Cardiovascular Biology and Medicine, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan aut International Journal of Clinical Oncology Springer Japan 20/5(2015-10-01), 872-877 1341-9625 20:5<872 2015 20 10147 https://doi.org/10.1007/s10147-015-0794-7 text/html Onlinezugriff via DOI BK010053 XK010053 XK010000 Metadata rights reserved Springer special CC-BY-NC licence nationallicence 1 research-article jats NATIONALLICENCE NATIONALLICENCE NL-springer NATIONALLICENCE 856 40 https://doi.org/10.1007/s10147-015-0794-7 text/html Onlinezugriff via DOI NATIONALLICENCE 700 1- Takayama Tsugumi Department of Cardiology, Niigata Cancer Center Hospital, Chu-o-ku Kawagishicho 2-15-3, 951-8560, Niigata, Japan aut NATIONALLICENCE 700 1- Okura Yuji Department of Cardiology, Niigata Cancer Center Hospital, Chu-o-ku Kawagishicho 2-15-3, 951-8560, Niigata, Japan aut NATIONALLICENCE 700 1- Okada Yoshinobu Department of Internal Medicine, Kamo Hospital, Niigata, Japan aut NATIONALLICENCE 700 1- Honma Keiichi Department of Pathology, Niigata Cancer Center Hospital, Niigata, Japan aut NATIONALLICENCE 700 1- Nashimoto Atsushi Department of Digestive Surgery, Niigata Cancer Center Hospital, Niigata, Japan aut NATIONALLICENCE 700 1- Sato Nobuaki Department of Breast Surgery, Niigata Cancer Center Hospital, Niigata, Japan aut NATIONALLICENCE 700 1- Yokoyama Akira Department of Respiratory Medicine, Niigata Cancer Center Hospital, Niigata, Japan aut NATIONALLICENCE 700 1- Minamino Tohru Department of Cardiovascular Biology and Medicine, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan aut NATIONALLICENCE 773 0- International Journal of Clinical Oncology Springer Japan 20/5(2015-10-01), 872-877 1341-9625 20:5<872 2015 20 10147